Skip to main content

Diffuse Large B-Cell Lymphoma

  • Reference work entry
  • First Online:
Encyclopedia of AIDS

Definition

Diffuse large B-cell lymphoma (DLBCL) is an AIDS-defining, aggressive lymphoid neoplasm in which normal lymph node architecture is replaced by sheets of large, atypical lymphoid cells. It is thought to arise from mature B cells and is comprised of large, noncleaved centroblasts and immunoblasts with abundant cytoplasm and prominent nucleoli. As the most common form of non-Hodgkin lymphoma (NHL) in both HIV-positive and HIV-negative individuals, there is an increasing appreciation of its morphologic, genetic, and biologic heterogeneity.

Epidemiology and Risk Factors

DLBCL accounts for roughly 30% of all NHLs in the HIV-negative population. By comparison, up to 75% of systemic NHL subtypes in HIV-seropositive individuals are comprised of DLBCL or variants thereof (Cote et al. 1997). As a whole, standardized incident ratios for NHL in HIV-positive individuals have decreased over the last two decades from over 1,000 in the early 1990s to below 200 in the mid-2000s due to the...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,099.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,599.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Antinori A, Cingolani A, Alba L, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS. 2001;15:1483–91.

    Article  CAS  PubMed  Google Scholar 

  • Bower M, Gazzard B, Mandalia S, et al. A prognostic index for systemic AIDS-related Non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. Ann Intern Med. 2005;143:265–73.

    Article  PubMed  Google Scholar 

  • Cote TR, Biggar RJ, Rosenberg PS, et al. Non-Hodgkin’s lymphoma among people with AIDS: incidence, presentation, and public health burden. Int J Cancer. 1997;73:645–50.

    Article  CAS  PubMed  Google Scholar 

  • Dunleavy K, Wilson W. How I treat HIV-associated lymphoma. Blood. 2012;119:3245–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fontaine J, Chagnon-Choquet J, Valcke HS, et al. High expression levels of B lymphocyte stimulator (BLyS) by dendritic cells correlate with HIV-related B-cell disease progression in humans. Blood. 2011;117(1):145–55.

    Article  CAS  PubMed  Google Scholar 

  • Hentrich M, Berger M, Hoffman C et al. PET scans in HIV-related Hodgkin lymphoma (HIV-HL): results of a retrospective study. J Clin Oncol. 2011;29:abstr 8044.

    Article  Google Scholar 

  • Kaplan LD, Lee JY, Ambinder RF, et al. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-malignancies consortium trial 010. Blood. 2005;106(5):1538–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kaplan LD, Ai W, Freedman A et al. AIDS-related lymphomas: epidemiology, risk factors, and pathobiology. UpToDate. Date last modified 10 Dec 2012.

    Google Scholar 

  • Krishnan A, Molina A, Zaia J, et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood. 2005;105:874–8.

    Article  CAS  PubMed  Google Scholar 

  • Levis M, Seifter E, Truong M. National Cancer Institute: PDQ® AIDS-related lymphoma treatment. National Cancer Institute, Bethesda. 2012. Date last modified 08 Oct 2012. Available at http://cancer.gov/cancertopics/pdq/treatment/AIDS-related-lymphoma/HealthProfessional.

  • Lim ST, Karim R, Tupule A, et al. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol. 2005;23(33):8477–82.

    Article  PubMed  Google Scholar 

  • Little RF, Pittaluga S, Grant N, et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood. 2003;101:4653–9.

    Article  CAS  PubMed  Google Scholar 

  • Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med. 2008;148(10):728–36.

    Article  PubMed  Google Scholar 

  • Re A, Michieli M, Casari S, et al. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. Blood. 2009;114:1306.

    Article  CAS  PubMed  Google Scholar 

  • Vishnu P, Aboulafia DM. AIDS-related non-Hodgkin’s lymphoma in the era of highly active antiretroviral therapy. Adv Hematol. 2012;2012:485943.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neel K. Gupta .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media LLC

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Gupta, N.K., Kaplan, L.D. (2018). Diffuse Large B-Cell Lymphoma. In: Hope, T.J., Richman, D.D., Stevenson, M. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7101-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7101-5_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-7100-8

  • Online ISBN: 978-1-4939-7101-5

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics